- Tevogen Bio is advancing evaluation of a potential CRO transaction expected to add $20 million+ in annual revenue and support double-digit growth.
- The target CRO operates across more than 20 countries, expanding Tevogen’s global clinical research delivery capabilities.
Tevogen Bio Holdings Inc. announced it is advancing its strategic evaluation of a potential contract research organization (CRO) transaction aimed at expanding clinical research delivery capabilities and supporting revenue growth. The company said the potential deal could add more than $20 million in annual revenue and contribute to double-digit growth.
The target CRO operates across more than 20 countries, which would expand Tevogen’s global clinical development footprint. The company said the potential transaction would strengthen its capabilities across oncology, rare diseases, and medical device programs while supporting a scalable clinical research model.
The CRO evaluation follows a previously announced letter of intent earlier in 2026 as part of Tevogen’s broader strategy to expand operational capabilities and diversify revenue streams. The company indicated that the potential acquisition aligns with efforts to build internal clinical development infrastructure and accelerate pipeline execution.
Tevogen said the proposed transaction is intended to improve efficiency in clinical trial execution and support faster development timelines. The company also noted that the move could create a pathway toward approximately $100 million in annual revenue over time, depending on transaction completion and integration progress.
“Advancing our strategic CRO evaluation marks an important step in expanding our clinical research delivery capabilities and driving revenue growth. By integrating additional clinical infrastructure, we aim to accelerate development timelines while building a scalable model to support long-term growth.”
Ryan Saadi, MD, MPH, Founder and Chief Executive Officer of Tevogen Bio
Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing. 
